企業プロフィール
Viracta Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- VIRX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for VIRX.
企業概要
事業概要
Viracta Therapeutics is an oncology company focused on virus-associated cancers and targeted cancer biology. Its platform aims to treat tumors linked to latent viral drivers.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Viracta sits in specialty oncology biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, target differentiation, and the ability to build a focused oncology franchise.
バイオ業界での位置付け
Viracta is a catalyst-sensitive oncology name whose stock reacts to early clinical and strategic updates.
今後のカタリスト
- Viracta’s catalysts are nanatinostat-based programs in EBV-positive lymphomas and any development update that keeps the antiviral-oncology story alive. The company still needs strong human data.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。